Manulife (Manufacturers Life Insurance)’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-103,484
| Closed | -$567K | – | 3226 |
|
|
2022
Q1 | $567K | Buy |
103,484
+78,225
| +310% | +$429K | ﹤0.01% | 2127 |
|
|
2021
Q4 | $247 | Buy |
25,259
+287
| +1% | +$3 | ﹤0.01% | 2760 |
|
|
2021
Q3 | $446K | Sell |
24,972
-1,516
| -6% | -$27.1K | ﹤0.01% | 2378 |
|
|
2021
Q2 | $647K | Buy |
26,488
+4,628
| +21% | +$113K | ﹤0.01% | 2253 |
|
|
2021
Q1 | $579K | Sell |
21,860
-3,161
| -13% | -$83.7K | ﹤0.01% | 2189 |
|
|
2020
Q4 | $190K | Buy |
25,021
+973
| +4% | +$7.39K | ﹤0.01% | 2799 |
|
|
2020
Q3 | $120K | Hold |
24,048
| – | – | ﹤0.01% | 2742 |
|
|
2020
Q2 | $152K | Sell |
24,048
-654
| -3% | -$4.13K | ﹤0.01% | 2610 |
|
|
2020
Q1 | $110K | Buy |
24,702
+1,605
| +7% | +$7.15K | ﹤0.01% | 2556 |
|
|
2019
Q4 | $219K | Sell |
23,097
-715
| -3% | -$6.78K | ﹤0.01% | 2537 |
|
|
2019
Q3 | $190K | Buy |
23,812
+734
| +3% | +$5.86K | ﹤0.01% | 2618 |
|
|
2019
Q2 | $363K | Buy |
23,078
+9,573
| +71% | +$151K | ﹤0.01% | 2246 |
|
|
2019
Q1 | $244K | Buy |
+13,505
| New | +$244K | ﹤0.01% | 2328 |
|